CLSDQ
Clearside Biomedical, Inc.
Set alert
0.25 USD 0.00 0.00%
0.249 Day range 0.31
0.01 52-week range 8.70
- YTD
- -64.68%
- 1 year
- -98.02%
- Open
- 0.31
- Prev close
- 0.249
- Mkt cap
- 1.30M
- Vol
- 106
- Avg vol
- 4.16K
- EPS
- -2.25
- P/E
- -0.11
More statistics
- Low
- 0.249
- High
- 0.31
Financials — quick view
CLSDQ Revenue — quarterly 0
CLSDQ Net income — quarterly -5.97M
CLSDQ EPS — quarterly -1.14
News
- Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
- Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Lags Revenue Estimates
- Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives Average Recommendation of “Hold” from Brokerages
- Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
- Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates
- Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada
- Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline
- Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
- Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know
- Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
Your note
Sign in to keep a note on CLSDQ — it syncs with the Stock Master app.